NCT04896567

Brief Summary

Endothelial progenitor cells that reside in renal vasculature may be stimulated to initiate differentiation programs during episodes of injury. It is hypothesized that endothelial progenitor cells resident in the kidney can transition to a post-injury phenotype that promotes endothelial repair.

Trial Health

30
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Jan 2022

Typical duration for phase_1

Geographic Reach
1 country

1 active site

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 31, 2018

Completed
2.7 years until next milestone

First Posted

Study publicly available on registry

May 21, 2021

Completed
8 months until next milestone

Study Start

First participant enrolled

January 21, 2022

Completed
1.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2024

Completed
Last Updated

August 3, 2022

Status Verified

July 1, 2022

Enrollment Period

1.9 years

First QC Date

August 31, 2018

Last Update Submit

July 31, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Cell growth

    Tissue will be isolated and cell viability will be documented by rate of colony growth over one week per patient enrolled.

    1 week

Secondary Outcomes (1)

  • Kidney disease progression

    3 years

Study Arms (1)

Intervention

EXPERIMENTAL

Patients will have kidney biopsy designated for cell isolation and culture.

Diagnostic Test: Cell isolation

Interventions

Cell isolationDIAGNOSTIC_TEST

Tissue from kidney biopsy will be used to isolate Cluster Differentiation 34+ cells.

Intervention

Eligibility Criteria

Age18 Years - 85 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Only patients who have a clinical indication for kidney biopsy will be considered.
  • All subjects will be at least 18 years of age and may be of any gender.
  • Patients undergoing a native or kidney transplant biopsy will be considered.

You may not qualify if:

  • Patients not undergoing a kidney biopsy will be excluded.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Brigham and Women's Hospital

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

Kidney Diseases

Interventions

Cell Separation

Condition Hierarchy (Ancestors)

Urologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital Diseases

Intervention Hierarchy (Ancestors)

Cytological TechniquesClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisInvestigative Techniques
0

Study Design

Study Type
interventional
Phase
phase 1
Allocation
NA
Masking
NONE
Purpose
BASIC SCIENCE
Intervention Model
SINGLE GROUP
Model Details: Consecutive patients will be consented to obtain kidney biopsy material.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

August 31, 2018

First Posted

May 21, 2021

Study Start

January 21, 2022

Primary Completion

December 30, 2023

Study Completion

December 30, 2024

Last Updated

August 3, 2022

Record last verified: 2022-07

Locations